Home » Newsletters » BioWorld Science

BioWorld Science

June 16, 2016

View Archived Issues

FDA grants QIDP designation to Amplyx Pharmaceuticals' APX-001

Bone Biologics signs agreement with UCLA to license Nell-1 for osteoporosis

QIAGEN launches QIAsure Methylation Test for cervical cancer

alpha-Synuclein specifically binds to TOM20 and inhibits mitochondrial protein import in human PD

Novel tracer targeting thymidine phosphorylase tested for the first time in humans

BARDA awards next option on contract to Atox Bio to support development of AB-103

PeptiDream earns milestone for the dosing of first patient in BMS clinical trial

Flex Pharma starts phase II study for FLX-787

Multilisa BICD2 test receives CE Mark

Roche patents cathepsin S inhibitors

Janssen Pharmaceutica discloses mGlu2 receptor negative allosteric modulators

Novartis expands partnership with MMV for the development of antimalarial compound KAF-156

Eli Lilly develops AICARFT inhibitors

Bayer Schering Pharma presents sGC activators

Aegerion Pharmaceuticals and QLT enter strategic merger agreement

Merck & Co. announces OX2 receptor antagonists

MRC Technology and AstraZeneca seek new epigenetic drug targets in respiratory disease

Oncolys BioPharma announces joint research agreement with Kyoto University

Argos Therapeutics and Adaptive Biotechnologies enter strategic research agreement

Zydus Cadila and Eczacibassi Ilac Pazarlama establish biosimilars strategic collaboration in Turkey

Worse progression-free survival seen in pelareorep treatment group in colorectal cancer trial

Long-term efficacy and safety of canakinumab

On-target activity and responses seen with BGB-324 in first study in leukemia patients

AnGes and Morishita Jintan enter agreement regarding rights to CIN treatment vaccine

FDA approves expanded label for Glassia

Apogenix reports topline results from phase I trial of APG-101

Cellceutix says phase II trial of brilacidin in ulcerative proctitis set to begin this week

Cibinetide receives two FDA orphan drug designations

TASP-0434299: a specific radioligand to vasopressin V1B receptor

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...